Andrew Krivoshik, MD, PhD
Andrew Krivoshik, MD, Ph.D. is a senior pharmaceutical executive with success in leading global multi-disciplinary cross-functional teams. Krivoshik has expertise in global clinical development including implementing novel and innovative clinical trial designs, is a subject matter expert and primary author of clinical protocols, investigator brochures, and regulatory submissions spanning the life cycle of clinical development, and is an invited speaker and session chair at international scientific congresses. He and his team have successfully submitted BLA, NDA, and sNDA applications leading to the approvals of new oncology medicines.
